This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. The text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.
Buyback (Sell directly to one of these merchants and get cash immediately)
|Currently there are no buyers interested in purchasing this book. While the book has no cash or trade value, you may consider donating it|